Listen Up

Sunday, December 29, 2024

Telehealth helps people get health care, but access may soon be in limbo



Telehealth bridges the distance between a patient and a provider, which can be especially beneficial for rural residents.


In some parts of the rural United States, accessing in-person health care can feel impossible. Local emergency rooms and specialists might be nonexistent, and a trip to the clinic can take hours.

Telehealth has changed the game. Stephen Martin, a family physician and addiction medicine specialist, has witnessed how the recent influx of virtual appointments has increased access to medical care for rural patients from his practice in Barre, Mass. People seeking long-term addiction treatment who may have shied away from health care in the past because of stigma in a small town or lack of transportation can now receive substantive treatment.


But no one knows how long telehealth will remain a viable option for many people on Medicare. Policies introduced during the COVID-19 pandemic made it easier for people in rural America to access virtual care, but some of these programs are now set to expire early next year.


While bipartisan support for the extensions remains, legislation that could implement them long-term is currently in limbo. The Medicare benefits, which were set to expire on December 31, were temporarily extended to March 31, 2025, under an emergency government funding bill signed by President Joe Biden on December 21. Come April, if the benefits aren’t extended again, many people living in rural America will face renewed hurdles to accessible care.


Health care in rural areas can be hard to access

Physician shortages, hospital closures, and the shuttering of critical services, such as labor and delivery care, have made it increasingly difficult to find reliable health care in rural areas (SN: 12/11/24). According to the Center for Healthcare Quality and Payment Reform, almost 200 rural hospitals have closed since 2005, leaving millions of people without emergency care or inpatient services in their communities. Late insurance payments and tight profit margins have left 360 more rural hospitals at risk of immediate closure. As of this year, there are about 1,200 rural hospitals throughout the country.


When these hospitals vanish, the patients they leave behind still fall ill and require care. People living in rural areas across the United States are more likely to die from heart disease, cancer, chronic lower respiratory disease and stroke than their urban counterparts, researchers reported in May in Morbidity and Mortality Weekly Report. Sixty-five percent of nonmetropolitan counties across the country lack a psychiatrist, and rural patients have higher rates of suicide and depression than urban residents, other studies have found.


If you don’t get along with the only doctor in town, Martin says, you’re in a tough spot. “You’re left to the idiosyncrasies and vantage points of any small number of practitioners in that area. So if those practitioners aren’t interested in addiction, you won’t have addiction care. If they’re not interested in mental health, you won’t have mental health care.”


Unsurprisingly, transportation to different providers is often a limiting factor for rural patients. For the millions of people living in rural parts of the country, it can take nearly twice as long to reach a hospital than it does for urban residents. Numbers vary wildly, but the average car travel time to the nearest hospital for someone in a rural area is 17 minutes; the average urban dweller needs just about 10 minutes. For people living in remote, hard-to-reach areas, it can take hours to reach in-person care.


There are patients who “literally have to take off an entire day of work to come and see us,” says U.S. Representative Gregory Murphy, a urologist who represents North Carolina’s 3rd District. “So many of the areas, sadly enough, in eastern North Carolina are rural and impoverished areas. So for people to lose half a day or a full day of work, it is a lot of lost wages.”


Telehealth legislation has been a boon for rural residents

In March 2020, isolation, quarantine, and fear of COVID-19 kept people away from healthcare centers. In response, Congress passed several temporary acts that expanded Medicare’s coverage of virtual care — for instance, patients could receive mental or behavioral telehealth care without visiting in person after an initial appointment. Telehealth use boomed. In-person appointments shifted to virtual ones. The number of telehealth users has since dropped but remains higher than pre-pandemic levels.


“Telemedicine is critical for access,” Seaman says. Finding a primary care doctor, a specialist to help manage chronic conditions, and a mental health practitioner might be a tall order in some rural counties. 


As the data roll in, scientists are learning that telehealth has the power to facilitate a diverse array of treatments. For example, doctors can virtually rehabilitate patients with chronic obstructive pulmonary disease, a lung disease with high prevalence in rural areas, and virtual mental health care can reduce depression symptoms and improve quality of life.


And for patients with opioid use disorder, virtual care can actually boost treatment retention, researchers reported in the December Journal of Substance Use and Addiction Treatment. Patients will stay and seek care for longer when the barriers are fewer.


Additionally, many people living in rural America might lack the technology necessary to chat over video. In 2020, the Federal Communications Commission reported that about 22 percent of rural Americans and 28 percent of people in what the agency classifies as Tribal Lands lacked broadband coverage, which is internet access quick enough to accomplish basic web-browsing tasks.


Researchers, policymakers, and healthcare workers have also shared concerns about telehealth’s impact on the quality of care. Some argue that technical difficulties during the pandemic inhibited certain care routines. Others argue that communication is impacted due to the loss of nonverbal cues from patients and clinicians.




Telehealth helps people get health care, but access may soon be in limbo

5 medical breakthroughs in 2024


Medical innovations in 2024 include progress in xenotransplantation and first-time FDA approvals, ABC News reported Dec. 23. 

Here are five medical breakthroughs from the past 12 months:

1. An 11-year-old boy who was born with a rare form of deafness caused by one gene mutation recently gained hearing from a gene therapy. Also, in a six-person clinical trial of children with a form of genetic deafness, five of the patients recovered their hearing. Both results were announced in January.  https://www.beckershospitalreview.com/patient-safety-outcomes/a-medical-first-gene-therapy-allows-boy-to-hear.html

2. In March, surgeons at Boston's Massachusetts General Hospital transplanted the world's first genetically edited pig kidney into a living human. The recipient, Richard Slayman, was a 62-year-old man with end-stage kidney disease. He later died from an unexpected cardiac event, the hospital said, adding that the field of xenotransplantation is growing and could offer hope for thousands of patients. 

3. Researchers at Brigham and Women's Hospital in Boston and Northwestern Medicine in Chicago have identified a potential cure for lupus. Patients with the autoimmune disease have an imbalance of T-cells, the researchers found and reported in a July Nature article.   https://www.nature.com/articles/s41586-024-07627-2
Based on this new information, they said either activating the aryl hydrocarbon receptor pathway with small molecule activators or limiting "the pathologically excessive interferon in the blood" could diminish the disease-causing cells. 

4. In September, the FDA approved the first schizophrenia treatment in more than 30 years. https://www.beckershospitalreview.com/pharmacy/fda-approves-schizophrenia-treatment.html
The drug, Cobenfy, is an oral capsule manufactured by Bristol-Myers Squibb. The twice-daily pill helped study participants manage common symptoms such as hallucinations, delusions, and disorganized thinking. 

5. The FDA also approved the first combination of COVID-19 and flu tests. In October, the Healgen Rapid Check COVID-19/Flu A&B Antigen Test received the regulatory green light for over-the-counter use.  https://www.beckershospitalreview.com/pharmacy/fda-approves-1st-combination-covid-flu-test-4-things-to-know.html
It can provide a result within 15 minutes for COVID-19 and influenza A and B. The test's accuracy is 99% for negative COVID-19 samples, 92% of positive COVID-19 samples, 99.9% for negative flu samples, and between 92.5% and 90.5% for positive samples of influenza A and influenza B, respectively.

6. Artificial intelligence and LLMs were introduced into the healthcare and medical workplace. Although controversial most physicians are utilizing this breakthrough for efficiency, and decreasing workload.  It is useful for diagnostics, image analysis, chatbots, as well as EHR scribing. AI is used for molecular modeling for the production of new drugs.   AI creates an exponential paradigm shift for medicine and a catalytic innovation for medicine.  Rochester, Minn.-based Mayo Clinic already has 184 predictive AI models, 18 of which are in clinical use and 35 are in the research stages, said John Halamka, MD, president of Mayo Clinic Platform. The health system is also using generative AI to draft inbox messages for providers and experimenting with it to summarize clinical visits, listen and document ambiently, and automate administrative tasks.  By using AI Primary care and Specialty physicians will leverage their ability to diagnose and treat illness.
Physicians are evaluating AI and reviewing all decisions because AI can hallucinate and yield aberrant answers.  Breakthrough In Preemptive Detection Of AI Hallucinations Reveals Vital Clues To Writing Prompts That Keep Generative AI From Freaking Out














5 medical breakthroughs in 2024

Friday, December 27, 2024

Data analysis reveals common errors that prevent patients from getting results and how to prevent it

Data analysis reveals common errors that prevent patients from getting timely, accurate diagnoses

At least 1 in 20 US adults experience a diagnostic error each year, according to a 2017 study. Another study estimated that 795,000 Americans experience permanent disability or death each year due to misdiagnosis of dangerous diseases.

New data analysis from ECRI, a global patient safety nonprofit, found that issues processing medical tests, delays in referrals, and miscommunication among healthcare staff are key drivers of diagnostic errors.

ECRI's data analysis found that most errors (nearly 70 percent) occurred during the testing process – including when healthcare staff are ordering, collecting, processing, obtaining results, or communicating results. Twelve percent of errors occurred in the monitoring and follow-up phase; with nearly nine percent during the referral and consultation phase.

Of errors that occurred during testing, more than 23 percent were a result of a technical or processing error, like the misuse of testing equipment, a poorly processed specimen, or a clinician lacking the proper skill to conduct the test. Another 20 percent of testing errors were a result of mixed-up samples, mislabeled specimens, and tests performed on the wrong patient.


“It’s a common misconception that if a patient has a missed or incorrect diagnosis, their doctor came up with the wrong hypothesis after having all the facts,” said ECRI President and CEO Marcus Schabacker. “That does happen occasionally, but we found that was tied to less than 3 percent of diagnostic errors. What’s more likely to break the diagnostic process are technical, administrative, and communication-related issues. These represent system failures, where many small mistakes lead to one big mistake.” 

Causes of Diagnostic Error

Many factors can cause diagnostic errors, including miscommunication among providers; miscommunication between providers and patients; and systemic factors like productivity pressures that prevent providers from exploring all investigative options or from consulting other providers. In some of the cases ECRI analyzed, test results were not reviewed quickly enough by the provider who ordered them, or results were never communicated to the patient. Referrals to specialists or requests for additional consultations can complicate the process, presenting more potential failure points.

Health Equity Crisis

Although any patient can experience diagnostic error, women and racial and ethnic minorities are at greater risk, with one study pointing to a 20 to 30 percent increase in the likelihood they are misdiagnosed. This is due to many factors, including providers’ explicit or implicit biases; race-based biases in medical algorithms; barriers to care and insurance access; and communication barriers.  ECRI’s PSO data only included race and ethnicity of patients in 17 percent of the incidents related to diagnostic error – pointing to a need for the industry to more comprehensively include and analyze race and ethnicity data in the analysis of diagnostic equity.

ECRI’s Process

ECRI analyzed more than 3,000 patient safety adverse events and near-misses submitted to ECRI and the ISMP PSO in 2023 by healthcare providers around the US. The events were analyzed using a combination of querying free-text fields and natural language processing data, followed by manual validation. Of the 3,014 patient safety events, 1,011 were determined to be related to diagnostic errors, and then sorted into the appropriate step in the diagnostic process where the breakdown occurred.

 

Patient Stories

ECRI’s report includes de-identified examples of cases when diagnostic error impacted patient care. A woman experienced abdominal pain and abnormal vaginal bleeding for months. It took nearly a year for her to be diagnosed with metastatic uterine cancer, after numerous doctor visits and tests. MRIs were ordered, but not all the results were reviewed, as her symptoms worsened. Despite masses being detected on an ultrasound, a missed appointment and communication barriers delayed her diagnosis. She was finally diagnosed after severe pain led to hospitalization.

The study also analyzed what’s known as “near misses,” incidents when healthcare staff caught an oversight or error before it caused harm. In one such case, a patient who was scheduled for open-heart surgery had their procedure rightfully canceled after staff noticed a critical test hadn’t been performed: a carotid ultrasound. The ultrasound, ordered just in time, revealed he would have had a catastrophic surgical outcome if the surgery had proceeded as scheduled.

Advice for Patients

Although most of the diagnostic process is out of the patients’ control, Schabacker shared tips for patients seeking to improve the likelihood they get a prompt and accurate diagnosis.

“It is important patients ask questions to understand why their doctor is ordering tests, and are those tests urgent,” said Schabacker. “Schedule your appointments and tests quickly and follow up with your provider if you’re awaiting results. If possible, ask a family member or friend to join you in important appointments, to help ask questions and take notes.”

Best Practices for Healthcare Leaders

ECRI’s report identifies strategies healthcare organizations can execute to improve diagnostic safety, centered on the total systems safety approach and human-factors engineering.

“The problem of diagnostic safety comes down to the lack of a systems-based approach. Since there are multiple potential failure points, a single intervention is insufficient,” warned Schabacker.

Integrating EHR workflows, optimizing testing processes, tracking results, and establishing multidisciplinary diagnostic management teams to analyze safety events are listed as essential components of a diagnostic safety program. Staff should be encouraged to report errors and “near-misses” across all phases of the process to prevent what Schabacker calls a “common and destructive blame and shame culture” in some healthcare environments.

While it may be difficult to ensure all the steps are done, it requires a unified team of providers and patients to make it happen. Patients must be involved with the health care team to insure Patient-centered care.




Data analysis reveals common errors that prevent patients from getting

Is Prenatal Ultrasound Dangerous to the Fetus-warning content may be objectionable to some readers

 Warning content may be objectionable to some readers

The Forgotten Dangers of Ultrasound by A Midwestern Doctor

What no one tells you about having a healthy pregnancy

Read on Substack

•The medical field has had a long history of exposing mothers to “treatments” that harm their infants. After decades of work to stop routine x-raying of fetuses, the “safe and effective” practice of prenatal ultrasound (US) was adopted in its place.

•While US is thought to be safe, there are decades of research showing it can harm tissues. Initially, this was well recognized, but as the ultrasound industry took off, it became a forgotten side of medicine, and research in this area became almost impossible to conduct.

Almost every mother-to-be is subject to US examinations to detect fetal abnormalities and/or determine fetal sex. At times pregnancy is terminated if the fetus has severe abnormality. These congenital syndromes have poor survival statistics, and many babies with these conditions don't live past the first few weeks of life. 

Anencephaly
This neural tube defect is considered lethal, with a median postnatal survival of less than 24 hours. However, there have been rare cases of short-term survival into infancy. 
Renal agenesis
This severe congenital anomaly has a median postnatal survival of less than 24 hours. 
Thanatophoric dysplasia
This severe congenital anomaly has a median postnatal survival that is not reported. 



In this article, we will review the body of literature on the risks and benefits of prenatal US, alternatives to prenatal US, and the strategies for pregnant mothers we have found are the most helpful to ensure a healthy and vibrant child, along with strategies for preventing common pregnancy issues like miscarriages, pregnancy back pain, swelling, and preeclampsia.

During their medical training, each student is taught that every form of medical imaging has pros and cons (e.g., that a theoretical risk exists from x-rays), but that US is entirely safe and that its cons are due to the images it produces is dependent on the skill of the US operator (whereas other imaging modalities produce much more consistent results). Because of how those axioms frame the topic, it leads every medical student to unconsciously assume the US must be 100% safe.   Before we go further, I would like to review an important (forgotten) interview about US with Robert S. Mendelsohn, a courageous physician and one of the most influential dissident physicians in history (e.g., he paved the way for much of what people like me do now).  

Safe” Levels of Ultrasound


Very few physicians know that for decades, there was extensive debate over the safety of US, particularly for children in the womb, especially early in gestation (e.g., in 1980, one leading researcher stated “the possibility of hazard should be kept under constant review”). Sadly, this 1979 quote encapsulates much of what followed:

Present-day ultrasonic diagnostic machines use such small levels of energy that they would appear to be safe, but the possibility must never be lost sight of that there may be safety threshold levels possibly different for different tissues, and that with the development of more powerful and sophisticated apparatus, these may yet be transgressed.

Much of this amnesia was a result of the FDA in 1992, owing to divided opinions over safety in the US field deciding to raise the maximum allowable US strength from 94 mW/cm2 to 720 mW/cm2 so that higher quality imaging could be developed, at which point US effectively became “safe and effective.”



The rationale for this increase was twofold. First, the FDA wanted to have the standards be uniform (except for the eyes):  

The effects of fetal ultrasound may be very different at the early stages of pregnancy when formative stem cells are vulnerable EMF, radiation and ultrasound

The Aftermath

Sadly, once the FDA declared US levels below 720 mW/cm2 were “safe and effective,” that quickly resulted in:

•The previous research on the dangers of US becoming forgotten.

•Medical societies gradually shifting their guidelines to increasingly downplay the dangers of US.

•A massive increase in the use of US (not unlike what happened after the 1986 Vaccine Act gave vaccines legal immunity).

•US technicians not being trained in the dangers of US, and hence not being mindful of how to avoid damage to the fetus. For example, the higher intensity used in US, the “clearer” the image is, so technicians (who were primarily assessed on their ability to get clearer images) will frequently use much higher US intensities (or expose the fetus to excessively long ultrasound sessions)—situations which would both be avoided if they knew US was not “100% safe and effective.”

•Very lax oversight of the US output of commercially available US models, allowing many to have far higher outputs.

A review article in Anesthesiology November 2011, Vol. 115, 1109–1124

Wednesday, December 25, 2024

THE SPARK OF LIFE

 The Miracle and Science of Conception


At the moment of fertilization when a sperm enters the ovum there is a flash of light. The "spark of light" often referred to at conception is a metaphorical expression that captures the moment of fertilization when a sperm cell successfully merges with an egg. Scientifically, this phenomenon can be attributed to a release of calcium ions within the egg.

When the sperm penetrates the egg's membrane, it triggers a series of chemical reactions that lead to a significant influx of calcium ions into the egg. This event is sometimes accompanied by a brief flash of light, which can be observed using specialized imaging techniques. This calcium surge plays a crucial role in initiating the developmental processes that follow fertilization, such as the activation of the egg and the beginning of embryonic development.

Thus, while the "spark" is not literally a light in the way we typically think of it, it symbolizes the critical and transformative moment of conception in the biological sense.
 
As a result of the change in membrane potential from the calcium influx, no other sperm can penetrate the ovum.

Thursday, December 19, 2024

Florida is UnitedHealthcare’s 2nd largest market. What that means for insurance denials.

Florida is UnitedHealthcare’s 2nd largest market. What that means for insurance denials.  Experts say seniors need to be particularly aware of their rights as they become increasingly more likely to have their claims denied.

About 4 million people in Florida are insured by UnitedHealthcare, a company facing backlash after its CEO was shot to death in Manhattan, followed by public outrage over its pattern of coverage denials.

Florida represents UnitedHealthcare’s second largest market after Texas, providing coverage through employee plans, the Affordable Care Act open marketplace, and Medicare Advantage plans.

This week, the insurer’s prior authorization and coverage denials in the state drew the same anger and frustration seen nationwide on social media in the wake of the shooting. Florida lawyers, insurance advocates, and medical billing experts say being informed about UnitedHealthcare’s practices, making smart choices, and fighting back is critical, especially now that the insurer uses sophisticated artificial intelligence (AI) to deny approvals and claims. According to consumer research site, ValuePengiun, UnitedHealthcare denies claims at a rate nearly double the industry average and now faces a barrage of lawsuits, including hundreds in Florida.

How to make an appeal
Donovan said patients denied prior authorization or payment should dig through the insurer’s denial letter to find instructions for the appeal process.

“Your denial will include details as to why they are making this decision, so you have to counter that with the facts that support your argument,” she said.

The Patient Advocate Foundation has sample appeals letters on its website.

When planning an appeal, document every step of the process, advises Russel Lazega, a Dania Beach insurance claims lawyer.

“Don’t treat an internal appeal to the insurer informally,” Lazega said. “A lot of people call and talk to the insurance company and don’t document it.”

Documentation should include emails from the insurer to the patient or from the patient to a doctor or hospital.

“Gather a direct response to their denial from your doctor and add your additional medical records to it,” Lazega said.

Sometimes, that documentation is enough to win an appeal.

If unsuccessful, the next step is an external appeal to a company hired by the insurer. “It’s important to have your documentation in the file. Any documentation about your appeal won’t be looked at unless it’s already in the file. Adding it later is hard, so don’t give the insurance company that technical advantage,” Lazega said.

The final step is federal court.

Lazega said people in life-or-death medical situations tend to go this route. The patient pays legal fees, not the insurance company.

“UnitedHealthcare approves and pays about 90% of medical claims upon submission,” UnitedHealthcare said in a statement provided to the Sun Sentinel. “Importantly, of those that require further review, around one-half of one percent are due to medical or clinical reasons. Highly inaccurate and grossly misleading information has been circulated about our company’s treatment of insurance claims.

“We do not use AI to make adverse coverage determinations. Coverage decisions are based on CMS coverage criteria and the terms of the member’s plan.”

Does that mean each AI determination is reviewed by a human?










Florida is UnitedHealthcare’s 2nd largest market. What that means for insurance denials.

QVIN ? A laboratory test using menstrual blood

𝐇𝐨𝐰 𝐌𝐞𝐧𝐬𝐭𝐫𝐮𝐚𝐥 𝐁𝐥𝐨𝐨𝐝 𝐈𝐬 𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞


QVIN is a company that aims to provide persons with a menstrual cycle with an easy way of collecting menstrual blood for health screening.


"𝐇𝐨𝐰 𝐝𝐨𝐞𝐬 𝐭𝐡𝐞 𝐐-𝐏𝐚𝐝 𝐜𝐨𝐧𝐭𝐫𝐢𝐛𝐮𝐭𝐞 𝐭𝐨 𝐭𝐫𝐚𝐝𝐢𝐭𝐢𝐨𝐧𝐚𝐥 𝐥𝐚𝐛 𝐭𝐞𝐬𝐭𝐢𝐧𝐠, 𝐚𝐧𝐝 𝐰𝐡𝐚𝐭 𝐦𝐚𝐤𝐞𝐬 𝐦𝐞𝐧𝐬𝐭𝐫𝐮𝐚𝐥 𝐛𝐥𝐨𝐨𝐝 𝐚 𝐩𝐨𝐰𝐞𝐫𝐟𝐮𝐥 𝐭𝐨𝐨𝐥 𝐟𝐨𝐫 𝐡𝐞𝐚𝐥𝐭𝐡 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬?







𝐷𝑟. 𝑆𝑎𝑟𝑎, 𝑡ℎ𝑒 𝐶𝐸𝑂 𝑎𝑛𝑑 𝑐𝑜-𝑓𝑜𝑢𝑛𝑑𝑒𝑟 𝑜𝑓 𝑄𝑣𝑖𝑛, 𝑠𝑒𝑡 𝑜𝑢𝑡 𝑤𝑖𝑡ℎ 𝑡ℎ𝑒 𝑖𝑛𝑡𝑒𝑛𝑡 𝑜𝑓 𝑑𝑒𝑣𝑒𝑙𝑜𝑝𝑖𝑛𝑔 𝑡𝑒𝑐ℎ𝑛𝑜𝑙𝑜𝑔𝑦 𝑡𝑜 𝑒𝑛𝑎𝑏𝑙𝑒 𝑝𝑒𝑜𝑝𝑙𝑒 𝑡𝑜 𝑏𝑒 𝑚𝑜𝑟𝑒 𝑝𝑟𝑒𝑣𝑒𝑛𝑡𝑎𝑡𝑖𝑣𝑒 𝑎𝑏𝑜𝑢𝑡 𝑡ℎ𝑒𝑖𝑟 ℎ𝑒𝑎𝑙𝑡ℎ 𝑎𝑛𝑑 𝑠ℎ𝑒 𝑤𝑎𝑛𝑡𝑒𝑑 𝑡𝑜 𝑓𝑖𝑛𝑑 𝑎 𝑤𝑎𝑦 𝑡ℎ𝑎𝑡 𝑤𝑜𝑢𝑙𝑑 𝑎𝑙𝑙𝑜𝑤 𝑝𝑎𝑡𝑖𝑒𝑛𝑡𝑠 𝑡𝑜 𝑜𝑏𝑡𝑎𝑖𝑛 𝑐𝑙𝑖𝑛𝑖𝑐𝑎𝑙𝑙𝑦 𝑟𝑒𝑙𝑒𝑣𝑎𝑛𝑡 𝑖𝑛𝑓𝑜𝑟𝑚𝑎𝑡𝑖𝑜𝑛 𝑎𝑏𝑜𝑢𝑡 𝑡ℎ𝑒𝑖𝑟 ℎ𝑒𝑎𝑙𝑡ℎ 𝑟𝑒𝑔𝑢𝑙𝑎𝑟𝑙𝑦 𝑎𝑛𝑑 𝑛𝑜𝑛-𝑖𝑛𝑣𝑎𝑠𝑖𝑣𝑒𝑙𝑦. 𝑄𝑣𝑖𝑛'𝑠 𝑚𝑖𝑠𝑠𝑖𝑜𝑛 𝑖𝑠 𝑡𝑜 𝑒𝑚𝑝𝑜𝑤𝑒𝑟 𝑤𝑜𝑚𝑒𝑛 𝑤𝑖𝑡ℎ 𝑎𝑐𝑐𝑒𝑠𝑠 𝑡𝑜 𝑟𝑒𝑔𝑢𝑙𝑎𝑟 𝑖𝑛𝑠𝑖𝑔ℎ𝑡𝑠 𝑎𝑏𝑜𝑢𝑡 𝑡ℎ𝑒𝑖𝑟 ℎ𝑒𝑎𝑙𝑡ℎ 𝑓𝑜𝑟 𝑒𝑎𝑟𝑙𝑦 𝑑𝑒𝑡𝑒𝑐𝑡𝑖𝑜𝑛 𝑎𝑛𝑑 𝑚𝑜𝑛𝑖𝑡𝑜𝑟𝑖𝑛𝑔.

𝑄𝑣𝑖𝑛 𝑖𝑠 𝑡ℎ𝑒 𝑓𝑖𝑟𝑠𝑡 𝑎𝑛𝑑 𝑜𝑛𝑙𝑦 ℎ𝑒𝑎𝑙𝑡ℎ𝑐𝑎𝑟𝑒 𝑠𝑒𝑟𝑣𝑖𝑐𝑒 𝑡ℎ𝑎𝑡 𝑐𝑜𝑙𝑙𝑒𝑐𝑡𝑠 𝑚𝑒𝑛𝑠𝑡𝑟𝑢𝑎𝑙 𝑏𝑙𝑜𝑜𝑑 𝑠𝑎𝑚𝑝𝑙𝑒𝑠 𝑎𝑠 𝑎𝑛 𝑎𝑙𝑡𝑒𝑟𝑛𝑎𝑡𝑖𝑣𝑒 𝑡𝑜 𝑡𝑟𝑎𝑑𝑖𝑡𝑖𝑜𝑛𝑎𝑙𝑙𝑦 𝑐𝑜𝑙𝑙𝑒𝑐𝑡𝑒𝑑 𝑣𝑒𝑛𝑜𝑢𝑠 𝑏𝑙𝑜𝑜𝑑 𝑑𝑟𝑎𝑤𝑠. 𝑇ℎ𝑒 𝐹𝐷𝐴 𝑐𝑙𝑒𝑎𝑟𝑎𝑛𝑐𝑒 𝑚𝑎𝑘𝑒𝑠 𝑖𝑡 𝑝𝑜𝑠𝑠𝑖𝑏𝑙𝑒 𝑓𝑜𝑟 𝑡ℎ𝑒 𝑚𝑖𝑙𝑙𝑖𝑜𝑛𝑠 𝑜𝑓 𝑤𝑜𝑚𝑒𝑛 𝑖𝑛 𝐴𝑚𝑒𝑟𝑖𝑐𝑎 𝑤ℎ𝑜 𝑙𝑖𝑣𝑒 𝑤𝑖𝑡ℎ 𝑑𝑖𝑎𝑏𝑒𝑡𝑒𝑠 𝑡𝑜 𝑟𝑒𝑐𝑒𝑖𝑣𝑒 𝑚𝑜𝑛𝑖𝑡𝑜𝑟𝑖𝑛𝑔 𝑜𝑓 𝐴𝟣𝑐, 𝑢𝑠𝑖𝑛𝑔 𝑙𝑎𝑏𝑜𝑟𝑎𝑡𝑜𝑟𝑦 𝑡𝑒𝑠𝑡𝑠 𝑝𝑒𝑟𝑓𝑜𝑟𝑚𝑒𝑑 𝑜𝑛 𝑡ℎ𝑒 𝑄-𝑃𝑎𝑑. 𝑀𝑜𝑟𝑒 𝑏𝑟𝑜𝑎𝑑𝑙𝑦, 𝑡ℎ𝑖𝑠 𝑚𝑎𝑟𝑘𝑠 𝑎𝑛 𝑜𝑝𝑝𝑜𝑟𝑡𝑢𝑛𝑖𝑡𝑦 𝑓𝑜𝑟 𝑡𝑒𝑠𝑡𝑖𝑛𝑔 𝑖𝑚𝑝𝑜𝑟𝑡𝑎𝑛𝑡 𝑏𝑖𝑜𝑚𝑎𝑟𝑘𝑒𝑟𝑠 𝑓𝑜𝑟 𝑡ℎ𝑒 𝑚𝑜𝑟𝑒 𝑡ℎ𝑎𝑛 𝟪𝟢 𝑚𝑖𝑙𝑙𝑖𝑜𝑛 𝑝𝑒𝑜𝑝𝑙𝑒 𝑤ℎ𝑜 𝑚𝑒𝑛𝑠𝑡𝑟𝑢𝑎𝑡𝑒 𝑖𝑛 𝑡ℎ𝑒 𝑈.𝑆 𝑎𝑛𝑑 𝟣.𝟪 𝑏𝑖𝑙𝑙𝑖𝑜𝑛 𝑔𝑙𝑜𝑏𝑎𝑙𝑙𝑦.(...)

𝑄𝑣𝑖𝑛 𝑝𝑟𝑜𝑣𝑒𝑑 𝑡ℎ𝑒 𝑐𝑙𝑖𝑛𝑖𝑐𝑎𝑙 𝑟𝑒𝑙𝑒𝑣𝑎𝑛𝑐𝑦 𝑜𝑓 𝑚𝑒𝑛𝑠𝑡𝑟𝑢𝑎𝑙 𝑏𝑙𝑜𝑜𝑑 𝑓𝑜𝑟 𝑎 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑖𝑚𝑝𝑜𝑟𝑡𝑎𝑛𝑡 𝑏𝑖𝑜𝑚𝑎𝑟𝑘𝑒𝑟𝑠. 𝑇ℎ𝑒 𝑄-𝑃𝑎𝑑 𝑤𝑎𝑠 𝑖𝑛𝑖𝑡𝑖𝑎𝑙𝑙𝑦 𝑐𝑟𝑒𝑎𝑡𝑒𝑑 𝑡𝑜 𝑖𝑑𝑒𝑛𝑡𝑖𝑓𝑦 𝑏𝑖𝑜𝑚𝑎𝑟𝑘𝑒𝑟𝑠 𝑓𝑜𝑟 𝐻𝑃𝑉 𝑎𝑛𝑑 ℎ𝑎𝑠 𝑒𝑥𝑝𝑎𝑛𝑑𝑒𝑑 𝑎𝑛𝑑 𝑖𝑑𝑒𝑛𝑡𝑖𝑓𝑖𝑒𝑑 𝑎𝑑𝑑𝑖𝑡𝑖𝑜𝑛𝑎𝑙 𝑏𝑖𝑜𝑚𝑎𝑟𝑘𝑒𝑟𝑠 𝑡𝑜 𝑡𝑒𝑠𝑡 𝑓𝑜𝑟, 𝑖𝑛𝑐𝑙𝑢𝑑𝑖𝑛𝑔 𝑝𝑟𝑒/𝑑𝑖𝑎𝑏𝑒𝑡𝑒𝑠, 𝑎𝑛𝑒𝑚𝑖𝑎, 𝑓𝑒𝑟𝑡𝑖𝑙𝑖𝑡𝑦, 𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑜𝑝𝑎𝑢𝑠𝑒, 𝑒𝑛𝑑𝑜𝑚𝑒𝑡𝑟𝑖𝑜𝑠𝑖𝑠, 𝑎𝑛𝑑 𝑡ℎ𝑦𝑟𝑜𝑖𝑑 ℎ𝑒𝑎𝑙𝑡ℎ."

While this test is presently limited to diabetes management, it opens a new avenue to obtain blood samples for many other tests. The procedures will need to be evaluated and verified as accurate, by controlling samples of systemic venous blood. But what about males?

Wednesday, December 18, 2024

The Challenge of Primary Care in America

Mission Impossible for Primary Care

I am not your grandfather's doctor


The Replacement Doctors:

Electronic Health Record with Patient Portal, Appointment scheduling, messaging, online laboratory results,
Telehealth
Remote monitoring, and wearables
Artificial Intelligence for symptom diagnosis, treatment, and prognosis
At-home research with search engines
Social Media health sites, Community and Forums


Access to Care:
Many patients struggle to find primary care providers, especially in rural or underserved areas. Long wait times for appointments can further complicate access.

Workforce Shortages: There is a growing shortage of primary care physicians, which can lead to increased workloads and burnout among existing providers.

Health Disparities: Socioeconomic factors, cultural differences, and systemic inequalities can affect patient access to care and health outcomes.

Chronic Disease Management: The rising prevalence of chronic diseases requires ongoing management, putting additional pressure on primary care resources.

Integration of Technology: While telehealth and electronic health records (EHRs) can improve efficiency, they also present challenges related to implementation, training, and data security.

Reimbursement Models: Many primary care providers face financial pressures due to outdated reimbursement models that do not adequately compensate for the quality of care delivered.

Patient Engagement: Encouraging patients to take an active role in their health can be difficult, especially when dealing with diverse populations.

Mental Health Integration: There is a growing need to integrate mental health services into primary care, which can be challenging due to stigma and a lack of resources.

Regulatory Burdens: Navigating complex regulations and compliance requirements can be time-consuming and detract from patient care.

Continuity of Care: Ensuring that patients receive consistent and coordinated care, particularly when transitioning between different healthcare settings, can be a challenge.


Facebook Reel 

 

The Decline of the Doctor: From Healers to Providers – Let Doctors be Doctors

“Whenever a physician or a nurse was called a” provider” and whenever a patient was called a” consumer” one more angel died. When all the angels were dead, we would be left with a totally dehumanized health care system.” Rashi Fein, PhD. NEJM Vol 306, # 14,863-864

Not too long ago, doctors were considered some of the most revered and trusted figures in society—figures to whom people entrusted their health and even their lives. In many cultures, physicians were viewed as almost godlike, given their immense responsibility and the critical role they played in shaping life and death. But today, many doctors are referred to as “providers,” a term that strips away the respect and reverence once given to them. Instead of healers, they have become cogs in the massive machine of healthcare.

So, what happened? How did the medical profession go from being a deeply respected calling to being treated like any other service industry job? What does this shift mean for doctors and patients, and how can we restore the respect that doctors once enjoyed?

The Golden Age of Medicine: Doctors as Healers
Historically, doctors have held an esteemed role in society. The word doctor comes from the Latin docere, meaning “to teach,” and throughout history, physicians were viewed as educators of both body and mind. They didn’t just cure disease; they provided guidance on living a healthy life, preventing illness, and promoting mental well-being. In the past, doctors were seen as moral figures—people who were deeply committed to their patients, and often considered part of the family.

In the early 20th century and before, doctors were often highly respected individuals. They were not just viewed as professionals—they were regarded as trustworthy advisors who could guide individuals through the most vulnerable and critical moments of their lives. Healthcare was much less accessible back then, and patients depended on their physicians not only for medical expertise but also for compassion and wisdom. People didn’t just visit doctors—they trusted them with their well-being.

The Shift: Healthcare Becomes a Business
However, after World War II, the healthcare landscape began to change dramatically, particularly in the United States. The introduction of private health insurance, the rise of large healthcare conglomerates, and the growth of pharmaceutical companies began to transform medicine into an increasingly industrialized business.

This shift was underscored by an explosion of healthcare costs. According to the Centers for Medicare & Medicaid Services (CMS), U.S. healthcare expenditures reached $4.3 trillion in 2021, a staggering 18.3% of the nation’s GDP. With these rising costs came the financialization of healthcare, where the focus began to shift from patient care to profit. As a result, healthcare started being viewed as an industry, with doctors no longer seen as healers but as part of the corporate machine.

The term “provider” began to replace “doctor,” signaling a shift in how healthcare professionals were viewed. Providers, as the term implies, were merely deliverers of a service, rather than esteemed practitioners of a noble art. Insurance companies, private equity firms, and large hospital networks gained more control over healthcare, leading to a more impersonal and transactional system.

This shift from personalized, patient-centered care to a corporate model significantly diminished the role of doctors as autonomous professionals, and, in many cases, reduced their autonomy. Doctors, now working for large health systems, found themselves less able to practice medicine in the way they saw fit, often pressured to meet the financial goals set by their employers.

The Burden of Bureaucracy: Technology, Paperwork, and Admin Overload
One of the major challenges that contributed to the devaluation of the doctor’s role is the growing administrative burden. With the rise of electronic health records (EHRs) and insurance bureaucracy, doctors spend an increasing amount of time on paperwork rather than on patient care. In fact, a 2019 survey by the American Medical Association (AMA) found that U.S. doctors spend an average of 16 hours a week on administrative tasks like EHR documentation, insurance claims, and compliance with government regulations.

This administrative burden has significant repercussions for the doctor-patient relationship. In the past, doctors were able to spend long, uninterrupted hours with patients, listening to their concerns and diagnosing their ailments with care and attention. But with the proliferation of bureaucratic tasks, doctors now face mounting pressure to see more patients, leaving little time for meaningful interactions.

The Mayo Clinic has noted that 50% of physicians report experiencing burnout, with high levels of administrative work being one of the key contributing factors. The growing use of technology, while beneficial in many ways, has inadvertently turned medicine into a data-management job for many doctors, rather than allowing them to focus on the healing process. As a result, doctors feel increasingly disconnected from the very art of medicine that once inspired them to enter the field.

Conclusion: Let’s Not Devalue the Profession Any Further
Doctors still hold an essential role in society. Healthcare has changed, but the art of healing has not disappeared. In fact, doctors are still fighting for their patients every day, often in the face of immense personal and professional challenges. They risk their lives, as we saw during the COVID-19 pandemic, working tirelessly to protect public health.

It’s time to stop devaluing the medical profession. We must recognize that doctors are not just “providers”—they are healers, educators, and advocates. The next time you see your doctor, remember that behind the white coat, they are doing their best to help you, despite the pressures they face.

If we want to restore the respect and dignity of the medical profession, we must work toward a healthcare system that values quality over efficiency, empathy over bureaucracy, and healing over profit. Let doctors be doctors again, and in doing so, we can ensure a healthier, more compassionate future for all.







The Decline of the Doctor: From Healers to Providers – Let Doctors be Doctors

Monday, December 16, 2024

Semaglutide Rocketing Past Statins as Millions Eligible

Statins are one of the 'go-to's' for reducing morbidity from hyper-lipid disorders causing arteriosclerosis heart disease, stroke, or other vascular thrombotic disorders.



About 40% of American adults — some 137 million — are eligible to take the glucagon-like peptide 1 (GLP-1) receptor agonist semaglutide, said the authors of a new study. The authors report that 35 million adults are eligible for semaglutide for diabetes, 129 million for weight management, and 8.9 million for secondary cardiovascular disease prevention.

Semaglutide for secondary prevention is likely to be an area of increased growth, as there is more insurance coverage for that indication, the authors wrote.
Currently, statins are the most commonly prescribed medication for American adults, with some 192 million prescriptions written in 2022, according to one estimate. The authors of a research letter published online in JAMA Cardiology estimate that at least 82 million American adults are eligible for statins.

Semaglutide will quickly overtake statins as the most prescribed pharmaceutical for American adults, said the authors. It was the top-selling drug in the United States in 2023, with sales of almost $14 billion, which made it worth taking a closer look at who might be eligible, said lead author Dhruv S. Kazi, MD, MS, associate professor of medicine at Harvard Medical School, Boston.
The use of these medications. is cost-effective. 

He and his colleagues at Beth Israel Deaconess Medical Center, Boston, the Harvard T.H. Chan School of Public Health, Boston, and the Feinberg School of Medicine at Northwestern, Chicago, used data from the National Health and Nutrition Examination Survey from 2015 to 2020 to determine how many American adults might be eligible for semaglutide. They focused on diabetes, weight management, and secondary prevention of cardiovascular disease, using inclusion and exclusion criteria from major randomized clinical trials of semaglutide in those indications.  According to recent studies, approximately 137 million American adults are considered eligible for semaglutide treatment, which represents more than half of the US adult population; this eligibility is based on factors like weight management, diabetes management, or cardiovascular disease prevention. 

References and studies that discuss the cost-effectiveness of statins in preventing heart disorders in the general population:

Mason et al. (2015) - This study evaluated the cost-effectiveness of statin therapy for primary prevention of cardiovascular disease in various populations. It found that statins are generally cost-effective, especially in individuals with elevated cardiovascular risk.
Sculpher et al. (2004) - This research presented a model assessing the cost-effectiveness of statins for primary and secondary prevention of cardiovascular disease. The study concluded that statins are cost-effective for primary prevention in high-risk groups.

National Institute for Health and Care Excellence (NICE) - NICE guidelines provide a comprehensive analysis of the cost-effectiveness of statins in preventing cardiovascular diseases. Their recommendations suggest that statins are cost-effective for individuals with a 10% or greater risk of cardiovascular events over 10 years.

Hernandez et al. (2012) - This study analyzed the economic implications of statin therapy in the general population, demonstrating that widespread implementation in individuals aged 40-75 years with varying risk levels is cost-effective.

Graham et al. (2011) - This research evaluated the cost-effectiveness of statins in older adults, showing significant health benefits that justify the costs associated with long-term statin use for preventing heart disorders.







Semaglutide Rocketing Past Statins as Millions Eligible

UnitedHealth Limits Access to Key Treatment for Kids With Autism —

United Health Care just cannot get it right. No matter, they don't care.


The diagnosis of autism (a neurodivergent diagnosis) has been made more often during the last decade. Many physicians and research programs are investigating the epidemiology of the diagnosis.

Secret Playbook: Leaked documents show that UnitedHealth is aggressively targeting the treatment of thousands of children with autism across the country to cut costs.   In internal reports, the company acknowledges that the therapy called applied behavior analysis, is the “evidence-based gold standard treatment for those with medically necessary needs.” But the company’s costs have climbed as the number of children diagnosed with autism has ballooned; experts say greater awareness and improved screening have contributed to a fourfold increase in the past two decades — from 1 in 150 to 1 in 36.
Critical Therapy: Applied behavior analysis has been shown to help kids with autism; many are covered by Medicaid, federal insurance for poor and vulnerable patients.

United administers Medicaid plans or benefits in about two dozen states and for more than 6 million people, including nearly 10,000 children with autism spectrum disorder. Optum expects to spend about $290 million for ABA therapy within its Medicaid plans this year, and it anticipates the need to increase, documents show. The number of Medicaid patients accessing specialized therapy has increased by about 20% over the past year, with expenses rising by about $75 million year-on-year.

UHC proactively analyzed the increased requests for advanced behavioral therapy calculating it would deny authorizations for treatment based solely upon the diagnosis. This diagnosis would exclude treatment for this disorder even if the benefits included behavioral therapy.


UnitedHealth Limits Access to Key Treatment for Kids With Autism — ProPublica